Microchimeric Cell Tranfer From Mother to Child - Pilo Study

NCT05250219 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 80

Last updated 2022-02-22

No results posted yet for this study

Summary

Microchimeric cells are known to be transferred from mother to child through the placenta. However it has been postulated that they could also be transferred through breastfeeding.

This study is designed to analyse lymphoid and digestive tract tissues (tonsils and appendixes) in male infants (or young adults) to research microchimeric female cells and try to correlate the frequency and localisation of said cells to the breastfeeding status during early infancy

Conditions

  • Breastfeeding

Sponsors & Collaborators

  • University Hospital, Montpellier

    lead OTHER

Principal Investigators

  • Boris DMITRENKO · UH MONTPELLIER - FRANCE

Eligibility

Min Age
1 Year
Max Age
16 Years
Sex
MALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-09-01
Primary Completion
2022-12-01
Completion
2022-12-31

Countries

  • France

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05250219 on ClinicalTrials.gov